1
|
Moni SS, Sultan MH, Alshahrani S, Tripathi P, Assiri A, Alqahtani SS, Bakkari MA, Madkhali OA, Alam MF, Alqahtani AH, Tripathi R, Pancholi SS, Ashafaq M, Elmobark ME. Physical characterization and wound healing properties of Zamzam water. BRAZ J BIOL 2022; 82:e262815. [PMID: 35976285 DOI: 10.1590/1519-6984.262815] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2022] [Accepted: 07/23/2022] [Indexed: 01/06/2023] Open
Abstract
The objective of the study was to evaluate the quality of Zamzam water, holy water for Muslims and consumed for its medicinal value. The present study demonstrates the physicochemical characterization and wound healing property of Zamzam water. The physicochemical characterization of Zamzam water samples was analyzed for dissolved oxygen, pH, conductivity, total dissolved solids, redox potential, zeta potential, polydispersity index, and zeta size. The microbial quality of Zamzam water was also assessed by exposing water samples to open air. In this work, Zamzam water was also screened for the medicinal value through wound healing properties in Wistar rats. Zamzam water exhibited a unique physicochemical characterization with high levels of dissolved oxygen, zeta potential, polydispersity index, redox potential, total dissolved solids, and conductivity before exposure to open air. After open air exposure, Zamzam water resisted the growth of bacteria. The wound healing properties of Zamzam water in vivo showed a 96% of healing effect on 12th day observation. The wound healing was achieved by modulating pro-inflammatory cytokine such as interleukin -1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor -α (TNF-α). Followed by the level of apoptosis markers caspase-9 and caspase-3 were reduced. The present study proved that Zamzam water is a good-quality water and showed excellent wound healing property. Therefore, Zamzam water can be used for pharmaceutical formulations.
Collapse
Affiliation(s)
- S S Moni
- Jazan University, College of Pharmacy, Department of Pharmaceutics, Jazan, Kingdom of Saudi Arabia
| | - M H Sultan
- Jazan University, College of Pharmacy, Department of Pharmaceutics, Jazan, Kingdom of Saudi Arabia
| | - S Alshahrani
- Jazan University, College of Pharmacy, Department of Pharmacology and Toxicology, Jazan, Kingdom of Saudi Arabia
| | - P Tripathi
- Jazan University, College of Pharmacy, Department of Pharmacology and Toxicology, Jazan, Kingdom of Saudi Arabia
| | - A Assiri
- King Khalid University, College of Pharmacy, Department of Clinical Pharmacy, Abha, Kingdom of Saudi Arabia
| | - S S Alqahtani
- Jazan University, College of Pharmacy, Department of Pharmacy Practice, Jazan, Kingdom of Saudi Arabia.,Jazan University, College of Pharmacy, Pharmacy Practice Research Unit, Jazan, Kingdom of Saudi Arabia
| | - M A Bakkari
- Jazan University, College of Pharmacy, Department of Pharmaceutics, Jazan, Kingdom of Saudi Arabia
| | - O A Madkhali
- Jazan University, College of Pharmacy, Department of Pharmaceutics, Jazan, Kingdom of Saudi Arabia
| | - M F Alam
- Jazan University, College of Pharmacy, Department of Pharmacology and Toxicology, Jazan, Kingdom of Saudi Arabia
| | - A H Alqahtani
- Al- Dawaa Medical Services, Co Ltd, Riyadh, Kingdom of Saudi Arabia
| | - R Tripathi
- Jazan University, College of Pharmacy, Department of Pharmacy Practice, Jazan, Kingdom of Saudi Arabia
| | - S S Pancholi
- Jazan University, College of Pharmacy, Department of Pharmaceutics, Jazan, Kingdom of Saudi Arabia.,Ganpat University, S. K. Patel College of Pharmaceutical Education and Research, Mahesana, Gujarat, India
| | - M Ashafaq
- Jazan University, College of Pharmacy, Department of Pharmacology and Toxicology, Jazan, Kingdom of Saudi Arabia
| | - M E Elmobark
- Jazan University, College of Pharmacy, Department of Pharmaceutics, Jazan, Kingdom of Saudi Arabia
| |
Collapse
|
2
|
Sterpione F, Mas K, Rippon MG, Rogers AA, Mayeux G, Rigaudier F, Chauvelot P, Robilliart L, Juhel C, Lecomte Y. The clinical impact of hydro-responsive dressings in dynamic wound healing: Part II. J Wound Care 2022; 31:56-67. [PMID: 35077216 DOI: 10.12968/jowc.2022.31.1.56] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
OBJECTIVE Over the course of a wound's healing trajectory, whether the wound is acute or hard-to-heal, management is likely to involve the use of several different dressing types. Minimising the complexity of treatment (in terms of dressing usage) would aid clinicians in providing effective wound care but excellent clinical outcomes must remain the primary goal. METHOD This study was an open-labelled, non-comparative study assessing the clinical effectiveness of a coordinated wound dressing treatment regimen. After an initial phase of using a hydro-responsive wound dressing (HydroClean, HRWD-1, PAUL HARTMANN AG, Germany) to cleanse and debride hard-to-heal wounds, the wounds were subsequently treated with either HydroTac (HRWD-2, PAUL HARTMANN AG, Germany) (to maintain healing progression and re-epithelialisation) or RespoSorb (a superabsorbent dressing, PAUL HARTMANN AG, Germany) (to manage moderate-to-high levels of exudate). The Pressure Ulcer Scale for Healing (PUSH) assessment tool was used to measure the wound status over the course of the treatment period and to assess several wound status parameters (for example, wound area, exudate levels and wound characteristics such as level of re-epithelialisation). RESULTS The results from this study demonstrated that wounds treated with HRWD-2 showed a positive healing response when using the PUSH score assessment tool with a significant mean reduction (p<0.0001) in the PUSH score of wounds treated with HRWD-2, with >75% of wounds being closed by the end of the study. This result underlines the effectiveness of HRWD-2 in supporting healing progression. CONCLUSION The results from this study support the coordinated use of HRWDs for the effective management and treatment of a variety of hard-to-heal wounds.
Collapse
Affiliation(s)
| | | | - Mark G Rippon
- University of Huddersfield, Queensgate, Huddersfield, UK.,Medical Marketing Consultant Daneriver Consultancy Ltd, Holmes Chapel, UK
| | | | | | | | | | | | | | - Yann Lecomte
- CEN Biotech, Dijon, Bourgogne Franche-Comté, France
| |
Collapse
|
3
|
Sterpione F, Mas K, Rippon M, Rogers A, Mayeux G, Rigaudier F, Chauvelot P, Robilliart L, Juhel C, Lecomte Y. The clinical impact of hydroresponsive dressings in dynamic wound healing: Part I. J Wound Care 2021; 30:15-24. [PMID: 33439084 DOI: 10.12968/jowc.2021.30.1.15] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
OBJECTIVE Management of any wound, either acute or hard-to-heal, might involve the use of multiple and different wound dressings in its treatment. This approach is necessary to overcome the myriad of clinical challenges the wound presents, as well as any underlying comorbidities that might affect the clinical outcomes. This article describes the clinical effectiveness of a coordinated wound dressing treatment regimen. METHOD This was an open-labelled non-comparative study involving patients with a variety of hard-to-heal and acute wounds of differing levels of severity, but all of which required removal of devitalised tissue to enable wound healing to progress. The first phase used the hydroresponsive wound dressing HydroClean (PAUL HARTMANN AG, Germany). The PUSH score was used as the primary measurement parameter. RESULTS A total of 86 patients (38 male/48 female), with a mean age of 67.7±21.7 years, took part in the study. The results showed that the hydroresponsive dressing was effective in managing wound exudate production and promoting wound cleansing and debridement, supporting good wound bed preparation. Wound closure was observed in 16/86 (18.6%) wounds at the end of the study (20 weeks). This enabled clinicians to switch to alternative wound dressings to promote subsequent clinical healing outcomes. CONCLUSION In this study, the hydroresponsive wound dressing was highly effective in preparing a clean wound bed such that the next stage of wound healing could be supported.
Collapse
Affiliation(s)
| | - Karine Mas
- Infirmière, 19 rue Paul Broca, 66100 Perpignan, France
| | - Mark Rippon
- Huddersfield University, Huddersfield, UK.,Daneriver Consultancy Ltd, Holmes Chapel, UK
| | | | | | | | | | | | | | - Yann Lecomte
- CEN Biotech, Dijon, Bourgogne-Franche-Comté, France
| |
Collapse
|
4
|
Banerjee K, Madhyastha R, Nakajima Y, Maruyama M, Madhyastha H. Nanoceutical Adjuvants as Wound Healing Material: Precepts and Prospects. Int J Mol Sci 2021; 22:4748. [PMID: 33947121 PMCID: PMC8124138 DOI: 10.3390/ijms22094748] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2021] [Revised: 04/26/2021] [Accepted: 04/27/2021] [Indexed: 02/07/2023] Open
Abstract
Dermal wound healing describes the progressive repair and recalcitrant mechanism of 12 damaged skin, and eventually, reformatting and reshaping the skin. Many probiotics, nutritional supplements, metal nanoparticles, composites, skin constructs, polymers, and so forth have been associated with the improved healing process of wounds. The exact mechanism of material-cellular interaction is a point of immense importance, particularly in pathological conditions such as diabetes. Bioengineered alternative agents will likely continue to dominate the outpatient and perioperative management of chronic, recalcitrant wounds as new products continue to cut costs and improve the wound healing process. This review article provides an update on the various remedies with confirmed wound healing activities of metal-based nanoceutical adjuvanted agents and also other nano-based counterparts from previous experiments conducted by various researchers.
Collapse
Affiliation(s)
- Kaushita Banerjee
- Department of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology, Vellore 632014, India;
| | - Radha Madhyastha
- Department of Applied Physiology, Faculty of Medicine, University of Miyazaki, Miyazaki 8891692, Japan; (R.M.); (Y.N.); (M.M.)
| | - Yuichi Nakajima
- Department of Applied Physiology, Faculty of Medicine, University of Miyazaki, Miyazaki 8891692, Japan; (R.M.); (Y.N.); (M.M.)
| | - Masugi Maruyama
- Department of Applied Physiology, Faculty of Medicine, University of Miyazaki, Miyazaki 8891692, Japan; (R.M.); (Y.N.); (M.M.)
| | - Harishkumar Madhyastha
- Department of Applied Physiology, Faculty of Medicine, University of Miyazaki, Miyazaki 8891692, Japan; (R.M.); (Y.N.); (M.M.)
| |
Collapse
|
5
|
Thibodeaux KT, Speyrer MS, Thibodeaux RP, Rogers AA, Rippon MG. Management of postoperative bleeding in surgically debrided wounds: topical haemostat versus electrocautery. J Wound Care 2020; 29:444-451. [PMID: 32804032 DOI: 10.12968/jowc.2020.29.8.444] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
OBJECTIVE To compare the effectiveness of a temporary topical external haemostat (OMNI-STAT Granules, Omni-stat Medical Inc., US) versus the use of electrocautery for bleeding control in patients who have undergone surgical wound debridement. Time saved in the operating room (OR) was evaluated. METHOD A prospective evaluation of use of a topical haemostat in an OR setting was compared with retrospective data collected using electrocautery to understand the time-saving benefits of using a topical haemostat versus electrocautery. RESULTS A total of 52 patients were treated with the topical haemostat, and 89 patients with electrocautery. The topical haemostat was shown to be as effective in achieving haemostasis post-surgical debridement as electrocautery, with the added benefits of significant time savings in the OR (reducing the mean total OR time by 19.1%). Additionally, preprocedure and surgical procedure times in patients treated with the topical haemostat were significantly reduced. The results showed that wounds treated with the topical haemostat demonstrated a more advanced stage of healing, which may be a result of the lack of tissue damage demonstrated with the topical haemostat compared with electrocautery. CONCLUSION This study found that the temporary topical haemostat was equally as effective as cauterisation in achieving haemostasis. In addition, significant saving in OR time was demonstrated relative to electrocautery. The improved OR times may translate into increased cost-effectiveness, relative to electrocautery, by increasing the number of surgical cases per day and/or using resources more effectively to treat more patients. It may also enable bleeding control in the outpatient clinic or at the bedside, freeing up costly OR time and enabling more effective management of healthcare resources.
Collapse
Affiliation(s)
| | | | - Ryan P Thibodeaux
- Medical Data Generation, Medical Management Ink, Opelousas, Louisiana, US
| | | | | |
Collapse
|